Abstract:Objective To investigate the effect of selenium on proliferation and apoptosis of chondrocytes of articular cartilage cultured in vitro in Kaschin-Beck disease(KBD) patients and normal person, to explore the role of selenium in control of KBD, and to provide evidence for selenium's effect on the growth of normal cartilage cells. Methods The articular cartilage samples of grade Ⅱ and Ⅲ KBD patients were selected according to the national "Clinical Diagnosis of KBD" (GB 16003-1995). Chondrocytes of 5 KBD and 5 non-endemic normal accidentswere separated and cultured in vitro. KBD group and control group were given different doses of selenium (0,0.0125,0.0250,0.0500,0.1000,0.2500,0.5000,1.0000 mg/L, respectively). Methyl thiazolyl tetrazolium (MTT),flow cytometric analysis, and immunocytochemical staining were used to observe the effect of selenium on cell growth and apoptosis in KBD and normal persons. Results MTT results showed that the cell proliferation rate in each dosage group of the control group at the 6th day(0.086 ± 0.025,0.077 ± 0.012,0.073 ± 0.027,0.071 ± 0.017,0.058 ± 0.028,0.052 ± 0.028 and 0.046 ± 0.037) was significantly lower than that of 0 mg/L group(0.138 ± 0.026,all P ＜ 0.05);the average cell proliferation rate was negative( - 0.001 ± 0.001, - 0.003 ± 0.000, - 0.003 ± 0.001and - 0.004 ± 0.001 ) in 0.1000 - 1.0000 mg/L dose group, which was significantly lower than that of the 0 mg/L group(0.025 ± 0.003, all P ＜ 0.05);compared with 0 mg/L group(0. 115 ± 0.011), the KBD 0.2500 mg/L dose group promoted cell proliferation(0.128 ± 0.037, P ＜ 0.05), the KBD 1.0000 mg/L dose group inhibited cell growth (0.071 ± 0.019, P ＜ 0.05). The apoptotic rate of 0.0500 - 1.0000 mg/L dose control group [ (18.88 ± 0.02)%,(17.58 ± 0.01)%, (17.09 ± 0.04)%, (56.00 ± 0.02)%, (57.85 ± 0.03)% ] were higher than that of the 0 mg/L group[(13.51 ± 0.01)%, all P ＜ 0.05];compared with 0 mg/L group[(25.84 ± 0.02)%], the apoptotic rate in KBD 0.0250 - 0.2500 mg/L dose group [ ( 13.69 ± 0.02) %, ( 15.96 ± 0.03 ) %, ( 16.68 ± 0.03 ) %, ( 16.67 ± 0.02) % ]were lower, and the apoptotic rate in 0.5000, 1.0000 mg/L dose group [ (59.58 ± 0.03)%, (73.48 ± 0.04)% ] were significantly higher(all P ＜ 0.05). The Fas expression in KBD 0.0500 - 0.2500 mg/L dose groups[ (41.2 ± 1.5)%,(40.3 ± 2.0)%, (50.2 ± 2.5)%] were lower than those of the same dose control group with selenium intervention [(52.4 ± 1.0)%, (67.2 ± 4.0)%, (75.1 ± 5.0)%, all P ＜ 0.05], the caspase-3 expression in KBD 0.0500,0.1000 mg/L dose groups[ (40.8 ± 1.1 )%, (45.1 ± 2.1 )%] were lower than those of the same dose control group with selenium intervention[ (68.0 ± 3.0)%, (70.6 ± 3.5)%, all P ＜ 0.05 ]. Conclusions Appropriate dose of selenium supplementation (0.1000 - 0.2500 mg/L) could promote the growth of KBD chondrocyte, decrease cell apoptosis,but have a damage when the dose of selenium ＞ 0.5000 mg/L;doses of selenium that could promote the growth of KBD chondrocyte does not mean to promote the growth of normal cartilage cells in vivo.

[Butenolide Induces Apoptosis of Cultured Chondrocytes: Study of Its Mechanism].

[Toxic Effect of Butenolide on Chondrocyte Differentiation and the Protective Effect of Selenium].

The Toxic Effects of Butenolide on Chondrocytes and the Protective Effects of Vitamin C, Vitamin E and Selenium

Effect Of Quercetin On Interleukin-1 Beta-Induced Apoptosis Of Chondrocyte

Butenolide induced cytotoxicity by disturbing the prooxidant-antioxidant balance, and antioxidants partly quench in human chondrocytes.

Effects of Selenium And/or Iodine Deficiency on Chondrocyte Apoptosis in Rats

Effect of T-2 Toxin and Selenium on P53,Bcl-xL and Caspase-3 Protein Expression in Chondrocytes

The experimental study of toxic effects of butenolide on the cultural chondrocytes

T-2 Toxin Induces Apoptosis, and Selenium Partly Blocks, T-2 Toxin Induced Apoptosis in Chondrocytes Through Modulation of the Bax/Bcl-2 Ratio

Effect of T-2 Toxin on P53,Bcl-xL and Caspase-3 Expression in Chondrocytes

Arsenic trioxide promotes ERK1/2-mediated phosphorylation and degradation of BIMEL to attenuate apoptosis in BEAS-2B cells

Effects of Oxidative Damage on Selenoprotein Gene Expression in Articular Chondrocytes and the Mechanism of Selenium

Sodium Selenite Induces Apoptosis Via ROS‐mediated NF‐κB Signaling and Activation of the Bax–caspase‐9–caspase‐3 Axis in 4T1 Cells

Effect of Selenium on Proliferation and Apoptosis of Kaschin-Beck Disease Chondrocyte Cultured in Vitro

Promotion of SIRT1 Protein Degradation and Lower SIRT1 Gene Expression Via Reactive Oxygen Species is Involved in Sb-induced Apoptosis in BEAS-2b Cells

Effects of Sodium Selenite on C-Jun N-terminal Kinase Signalling Pathway Induced by Oxidative Stress in Human Chondrocytes and C-Jun N-terminal Kinase Expression in Patients with Kashin–Beck Disease, an Endemic Osteoarthritis

Effects of T-2 Toxin on the Mrna Expression of Apoptosis-Related Gene in Articular Chondrocytes of Selenium-Deficiency Rats

Butein Sensitizes Hela Cells To Cisplatin Through The Akt And Erk/P38 Mapk Pathways By Targeting Foxo3a

Butein induces apoptosis in human uveal melanoma cells through mitochondrial apoptosis pathway

The regulatory effects of miR-138-5p on selenium deficiency-induced chondrocyte apoptosis are mediated by targeting SelM

Effects of Selenium Nanoparticles and Sodium Selenite on Apoptosis and Reactive Oxygen Species in Chondrocytes from Articular Cartilage in Patients with Kashin-Beck Disease